Your browser doesn't support javascript.
loading
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus.
Su, Hang; Ye, Xiaohua; Freed, Daniel C; Li, Leike; Ku, Zhiqiang; Xiong, Wei; Gao, Peng; Liu, Xinli; Montgomery, Diana; Xu, Weifeng; Espeseth, Amy S; Wang, Dai; Ma, Ningning; Fu, Tong-Ming; Zhang, Ningyan; An, Zhiqiang.
Afiliação
  • Su H; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China.
  • Ye X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Freed DC; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Li L; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Ku Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Xiong W; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Gao P; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Liu X; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA.
  • Montgomery D; University of Houston College of Pharmacy, Houston, Texas, USA.
  • Xu W; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Espeseth AS; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Wang D; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Ma N; Merck Research Laboratories, Merck & Co., Inc., Kenilworth, New Jersey, USA.
  • Fu TM; Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, China maningning@syphu.edu.cn Tong-Ming.Fu@uth.tmc.edu Ningyan.zhang@uth.tmc.edu.
  • Zhang N; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA maningning@syphu.edu.cn Tong-Ming.Fu@uth.tmc.edu Ningyan.zhang@uth.tmc.edu.
  • An Z; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, Texas, USA maningning@syphu.edu.cn Tong-Ming.Fu@uth.tmc.edu Ningyan.zhang@uth.tmc.edu.
Antimicrob Agents Chemother ; 65(3)2021 02 17.
Article em En | MEDLINE | ID: mdl-33361306
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Citomegalovirus Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Citomegalovirus / Citomegalovirus Limite: Animals / Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China